Form D · Other Health Care
bioTheranostics, Inc.
San Diego, CA · CIK 0001665382
Offering snapshot reported Feb 4, 2016 · SEC filing
- Reported sold
- $20M Offering amount: $32M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 20, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 4, 2016 | Initial | $20,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.62M
- Finders' fees
- $0
- Form D file number
- 021-256767
Sales commission paid to Piper Jaffray & Co. - CRD 665
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Piper Jaffray & Co. | 665 |
Source: Form D, filed Feb 4, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas Barthelemy | Director, Executive, Promoter |
| Eric Bednarski | Director |
| David Kabakoff | Director |
| Alejandro Sanchez | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
9620 Towne Centre Drive Suite 200
San Diego, CA, 92121
San Diego, CA, 92121